nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—CYP3A4—prostate cancer	0.141	0.505	CbGaD
Phenylbutazone—PTGS2—prostate cancer	0.138	0.495	CbGaD
Phenylbutazone—SLC22A11—Conjugated Estrogens—prostate cancer	0.0656	0.123	CbGbCtD
Phenylbutazone—SLC22A11—Estradiol—prostate cancer	0.0576	0.108	CbGbCtD
Phenylbutazone—SLC22A8—Conjugated Estrogens—prostate cancer	0.0381	0.0718	CbGbCtD
Phenylbutazone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0345	0.0648	CbGbCtD
Phenylbutazone—SLC22A8—Estradiol—prostate cancer	0.0335	0.063	CbGbCtD
Phenylbutazone—CYP2C9—Bicalutamide—prostate cancer	0.0311	0.0586	CbGbCtD
Phenylbutazone—CYP2C9—Nilutamide—prostate cancer	0.0311	0.0586	CbGbCtD
Phenylbutazone—SLC22A6—Conjugated Estrogens—prostate cancer	0.0266	0.05	CbGbCtD
Phenylbutazone—PTGS2—Etoposide—prostate cancer	0.0206	0.0387	CbGbCtD
Phenylbutazone—CYP2C9—Estrone—prostate cancer	0.0186	0.0351	CbGbCtD
Phenylbutazone—CYP3A4—Bicalutamide—prostate cancer	0.0181	0.034	CbGbCtD
Phenylbutazone—PTGS1—Etoposide—prostate cancer	0.0174	0.0327	CbGbCtD
Phenylbutazone—CYP3A4—Estramustine—prostate cancer	0.0168	0.0317	CbGbCtD
Phenylbutazone—CYP3A4—Flutamide—prostate cancer	0.015	0.0282	CbGbCtD
Phenylbutazone—CYP3A4—Abiraterone—prostate cancer	0.015	0.0282	CbGbCtD
Phenylbutazone—CYP2C9—Capecitabine—prostate cancer	0.0141	0.0266	CbGbCtD
Phenylbutazone—CYP3A4—Cabazitaxel—prostate cancer	0.0111	0.0209	CbGbCtD
Phenylbutazone—CYP3A4—Estrone—prostate cancer	0.0108	0.0204	CbGbCtD
Phenylbutazone—CYP2C9—Estradiol—prostate cancer	0.0107	0.0201	CbGbCtD
Phenylbutazone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00966	0.0182	CbGbCtD
Phenylbutazone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00709	0.0133	CbGbCtD
Phenylbutazone—CYP3A4—Mitoxantrone—prostate cancer	0.00645	0.0121	CbGbCtD
Phenylbutazone—CYP3A4—Estradiol—prostate cancer	0.00623	0.0117	CbGbCtD
Phenylbutazone—CYP3A4—Prednisone—prostate cancer	0.00536	0.0101	CbGbCtD
Phenylbutazone—PTGIS—prostate gland—prostate cancer	0.00431	0.159	CbGeAlD
Phenylbutazone—CYP3A4—Etoposide—prostate cancer	0.00407	0.00765	CbGbCtD
Phenylbutazone—SLC22A8—urine—prostate cancer	0.00379	0.14	CbGeAlD
Phenylbutazone—CYP3A4—Docetaxel—prostate cancer	0.00372	0.007	CbGbCtD
Phenylbutazone—CYP3A4—Doxorubicin—prostate cancer	0.00277	0.00522	CbGbCtD
Phenylbutazone—CYP2C9—urine—prostate cancer	0.00246	0.0911	CbGeAlD
Phenylbutazone—PTGIS—testis—prostate cancer	0.0019	0.0702	CbGeAlD
Phenylbutazone—CYP3A4—urine—prostate cancer	0.00188	0.0695	CbGeAlD
Phenylbutazone—SLC22A11—renal system—prostate cancer	0.00164	0.0608	CbGeAlD
Phenylbutazone—PTGIS—lymph node—prostate cancer	0.00138	0.0509	CbGeAlD
Phenylbutazone—SLC22A8—prostate gland—prostate cancer	0.00136	0.0503	CbGeAlD
Phenylbutazone—SLC22A8—renal system—prostate cancer	0.000928	0.0343	CbGeAlD
Phenylbutazone—PTGS1—prostate gland—prostate cancer	0.000808	0.0299	CbGeAlD
Phenylbutazone—PTGS2—prostate gland—prostate cancer	0.000772	0.0285	CbGeAlD
Phenylbutazone—PTGS1—seminal vesicle—prostate cancer	0.000683	0.0253	CbGeAlD
Phenylbutazone—PTGS2—seminal vesicle—prostate cancer	0.000653	0.0241	CbGeAlD
Phenylbutazone—PTGS1—epithelium—prostate cancer	0.000593	0.0219	CbGeAlD
Phenylbutazone—PTGS2—epithelium—prostate cancer	0.000567	0.021	CbGeAlD
Phenylbutazone—PTGS1—renal system—prostate cancer	0.00055	0.0204	CbGeAlD
Phenylbutazone—PTGS2—renal system—prostate cancer	0.000526	0.0195	CbGeAlD
Phenylbutazone—PTGS2—urethra—prostate cancer	0.000517	0.0191	CbGeAlD
Phenylbutazone—CYP3A4—renal system—prostate cancer	0.00046	0.017	CbGeAlD
Phenylbutazone—PTGS2—bone marrow—prostate cancer	0.000398	0.0147	CbGeAlD
Phenylbutazone—PTGS1—testis—prostate cancer	0.000356	0.0132	CbGeAlD
Phenylbutazone—PTGS1—lymph node—prostate cancer	0.000258	0.00954	CbGeAlD
Phenylbutazone—PTGS2—lymph node—prostate cancer	0.000247	0.00912	CbGeAlD
Phenylbutazone—Clobazam—CYP2C18—prostate cancer	0.00024	0.063	CrCbGaD
Phenylbutazone—Phenoxybenzamine—SLC22A3—prostate cancer	0.000233	0.0611	CrCbGaD
Phenylbutazone—Fosphenytoin—CYP2C19—prostate cancer	0.000222	0.0583	CrCbGaD
Phenylbutazone—Phenytoin—CYP2C18—prostate cancer	0.000219	0.0574	CrCbGaD
Phenylbutazone—Diphenhydramine—CYP2C18—prostate cancer	0.000171	0.045	CrCbGaD
Phenylbutazone—Phenoxybenzamine—SLC22A1—prostate cancer	0.000167	0.0438	CrCbGaD
Phenylbutazone—Methadone—CYP2C18—prostate cancer	0.000165	0.0434	CrCbGaD
Phenylbutazone—Modafinil—CYP3A5—prostate cancer	0.000162	0.0427	CrCbGaD
Phenylbutazone—Fentanyl—CYP3A5—prostate cancer	0.000159	0.0417	CrCbGaD
Phenylbutazone—Phenytoin—CYP3A5—prostate cancer	0.000144	0.0378	CrCbGaD
Phenylbutazone—Fosphenytoin—CYP3A4—prostate cancer	0.000141	0.0371	CrCbGaD
Phenylbutazone—Diphenhydramine—SLC22A1—prostate cancer	0.00014	0.0367	CrCbGaD
Phenylbutazone—Oxaprozin—PTGS2—prostate cancer	0.000133	0.0349	CrCbGaD
Phenylbutazone—Sulfinpyrazone—CYP3A4—prostate cancer	0.000126	0.0331	CrCbGaD
Phenylbutazone—Modafinil—CYP2C19—prostate cancer	0.000111	0.029	CrCbGaD
Phenylbutazone—Methadone—CYP3A5—prostate cancer	0.000109	0.0286	CrCbGaD
Phenylbutazone—Clobazam—CYP2C19—prostate cancer	0.000108	0.0282	CrCbGaD
Phenylbutazone—Phenoxybenzamine—ADRB2—prostate cancer	0.000106	0.0279	CrCbGaD
Phenylbutazone—Methadone—CYP19A1—prostate cancer	0.0001	0.0264	CrCbGaD
Phenylbutazone—Phenytoin—CYP2C19—prostate cancer	9.81e-05	0.0258	CrCbGaD
Phenylbutazone—Phenprocoumon—CYP3A4—prostate cancer	9.68e-05	0.0254	CrCbGaD
Phenylbutazone—Diphenhydramine—CYP2C19—prostate cancer	7.68e-05	0.0202	CrCbGaD
Phenylbutazone—Methadone—CYP2C19—prostate cancer	7.42e-05	0.0195	CrCbGaD
Phenylbutazone—Modafinil—CYP3A4—prostate cancer	7.03e-05	0.0185	CrCbGaD
Phenylbutazone—Dextropropoxyphene—CYP3A4—prostate cancer	6.95e-05	0.0183	CrCbGaD
Phenylbutazone—Fentanyl—CYP3A4—prostate cancer	6.88e-05	0.0181	CrCbGaD
Phenylbutazone—Clobazam—CYP3A4—prostate cancer	6.84e-05	0.018	CrCbGaD
Phenylbutazone—Phenytoin—CYP3A4—prostate cancer	6.24e-05	0.0164	CrCbGaD
Phenylbutazone—Benzphetamine—CYP3A4—prostate cancer	6.1e-05	0.016	CrCbGaD
Phenylbutazone—Phenoxybenzamine—CYP3A4—prostate cancer	5.83e-05	0.0153	CrCbGaD
Phenylbutazone—Methadone—CYP3A4—prostate cancer	4.72e-05	0.0124	CrCbGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.74e-06	3.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTA2—prostate cancer	5.73e-06	3.63e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.67e-06	3.59e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SULT1A1—prostate cancer	5.66e-06	3.59e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCG5—prostate cancer	5.66e-06	3.59e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—prostate cancer	5.65e-06	3.58e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—COMT—prostate cancer	5.61e-06	3.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HPGD—prostate cancer	5.59e-06	3.55e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—B4GALT4—prostate cancer	5.59e-06	3.55e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTP1—prostate cancer	5.58e-06	3.54e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF10—prostate cancer	5.57e-06	3.53e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTA1—prostate cancer	5.52e-06	3.5e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC5A5—prostate cancer	5.5e-06	3.49e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ITPR1—prostate cancer	5.5e-06	3.48e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NAT2—prostate cancer	5.46e-06	3.46e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HSD3B2—prostate cancer	5.46e-06	3.46e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTO1—prostate cancer	5.46e-06	3.46e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.4e-06	3.43e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP2E1—prostate cancer	5.38e-06	3.41e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NQO1—prostate cancer	5.32e-06	3.37e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFBR2—prostate cancer	5.29e-06	3.36e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	5.26e-06	3.33e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.25e-06	3.33e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TH—prostate cancer	5.24e-06	3.32e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LRP2—prostate cancer	5.24e-06	3.32e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLCB2—prostate cancer	5.24e-06	3.32e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2C18—prostate cancer	5.24e-06	3.32e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ITPR1—prostate cancer	5.21e-06	3.3e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.21e-06	3.3e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TYMS—prostate cancer	5.19e-06	3.29e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP3A4—prostate cancer	5.18e-06	3.29e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—P4HB—prostate cancer	5.14e-06	3.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTM1—prostate cancer	5.13e-06	3.25e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.11e-06	3.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTAP—prostate cancer	5.11e-06	3.24e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP1B1—prostate cancer	5.1e-06	3.23e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LPL—prostate cancer	5.04e-06	3.19e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC22A1—prostate cancer	5e-06	3.17e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.98e-06	3.16e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.98e-06	3.16e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.94e-06	3.13e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GGT1—prostate cancer	4.94e-06	3.13e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SULT2A1—prostate cancer	4.87e-06	3.09e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP1A1—prostate cancer	4.87e-06	3.09e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NCOA1—prostate cancer	4.86e-06	3.08e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ERCC2—prostate cancer	4.83e-06	3.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP19A1—prostate cancer	4.79e-06	3.04e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MED12—prostate cancer	4.79e-06	3.04e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LPL—prostate cancer	4.78e-06	3.03e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.75e-06	3.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACSL4—prostate cancer	4.75e-06	3.01e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GNG5—prostate cancer	4.75e-06	3.01e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFRB—prostate cancer	4.73e-06	3e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—prostate cancer	4.73e-06	3e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—RXRA—prostate cancer	4.62e-06	2.93e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOA3—prostate cancer	4.58e-06	2.9e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERCC2—prostate cancer	4.57e-06	2.9e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PHGDH—prostate cancer	4.56e-06	2.89e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ARG2—prostate cancer	4.56e-06	2.89e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—UMPS—prostate cancer	4.56e-06	2.89e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—prostate cancer	4.54e-06	2.88e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.5e-06	2.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.5e-06	2.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB3—prostate cancer	4.47e-06	2.84e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LDHB—prostate cancer	4.47e-06	2.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGFR2—prostate cancer	4.47e-06	2.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—COMT—prostate cancer	4.45e-06	2.82e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARA—prostate cancer	4.45e-06	2.82e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTP1—prostate cancer	4.43e-06	2.81e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.39e-06	2.78e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HPGDS—prostate cancer	4.37e-06	2.77e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ITPR1—prostate cancer	4.36e-06	2.77e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2C19—prostate cancer	4.34e-06	2.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—prostate cancer	4.3e-06	2.73e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.29e-06	2.72e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TERT—prostate cancer	4.29e-06	2.72e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTA3—prostate cancer	4.24e-06	2.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PDHA1—prostate cancer	4.24e-06	2.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TCN2—prostate cancer	4.24e-06	2.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—UCP3—prostate cancer	4.24e-06	2.69e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTT1—prostate cancer	4.24e-06	2.69e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ACHE—prostate cancer	4.24e-06	2.69e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2A6—prostate cancer	4.19e-06	2.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAV1—prostate cancer	4.18e-06	2.65e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.17e-06	2.64e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TYMS—prostate cancer	4.12e-06	2.61e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HIF1A—prostate cancer	4.1e-06	2.6e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTM1—prostate cancer	4.07e-06	2.58e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKR1C3—prostate cancer	4.07e-06	2.58e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PRKACB—prostate cancer	4.05e-06	2.57e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.04e-06	2.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.04e-06	2.56e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP17A1—prostate cancer	4.01e-06	2.54e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LPL—prostate cancer	4e-06	2.54e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4e-06	2.53e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CAV1—prostate cancer	3.97e-06	2.51e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.95e-06	2.51e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.88e-06	2.46e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTA4—prostate cancer	3.88e-06	2.46e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP1A1—prostate cancer	3.86e-06	2.45e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ERCC2—prostate cancer	3.83e-06	2.43e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOA2—prostate cancer	3.82e-06	2.42e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CG—prostate cancer	3.81e-06	2.42e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTA2—prostate cancer	3.78e-06	2.39e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCG5—prostate cancer	3.73e-06	2.37e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.73e-06	2.37e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BAD—prostate cancer	3.73e-06	2.37e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.64e-06	2.31e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTA1—prostate cancer	3.64e-06	2.31e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APC—prostate cancer	3.61e-06	2.29e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—INS—prostate cancer	3.61e-06	2.29e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTO1—prostate cancer	3.6e-06	2.28e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.6e-06	2.28e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NAT2—prostate cancer	3.6e-06	2.28e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—prostate cancer	3.6e-06	2.28e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGF—prostate cancer	3.57e-06	2.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IRS1—prostate cancer	3.57e-06	2.26e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.56e-06	2.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CREBBP—prostate cancer	3.53e-06	2.24e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARA—prostate cancer	3.53e-06	2.24e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NQO1—prostate cancer	3.52e-06	2.23e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TH—prostate cancer	3.47e-06	2.2e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GSK3B—prostate cancer	3.47e-06	2.2e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLCB2—prostate cancer	3.45e-06	2.19e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.45e-06	2.19e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LRP2—prostate cancer	3.45e-06	2.19e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.45e-06	2.19e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.43e-06	2.18e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—INS—prostate cancer	3.42e-06	2.17e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.42e-06	2.17e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—P4HB—prostate cancer	3.39e-06	2.15e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.37e-06	2.14e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CD—prostate cancer	3.35e-06	2.12e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CREBBP—prostate cancer	3.35e-06	2.12e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAV1—prostate cancer	3.32e-06	2.11e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.3e-06	2.09e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GGT1—prostate cancer	3.27e-06	2.07e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOA1—prostate cancer	3.22e-06	2.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.21e-06	2.04e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAP2K1—prostate cancer	3.2e-06	2.03e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CD—prostate cancer	3.18e-06	2.01e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.17e-06	2.01e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.17e-06	2.01e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NOS3—prostate cancer	3.16e-06	2.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MED12—prostate cancer	3.16e-06	2e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SERPINE1—prostate cancer	3.14e-06	1.99e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GNG5—prostate cancer	3.13e-06	1.99e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—RXRA—prostate cancer	3.06e-06	1.94e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF2—prostate cancer	3.04e-06	1.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CG—prostate cancer	3.03e-06	1.92e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOA3—prostate cancer	3.02e-06	1.91e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS3—prostate cancer	3e-06	1.9e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.98e-06	1.89e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—COMT—prostate cancer	2.95e-06	1.87e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTP1—prostate cancer	2.94e-06	1.86e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CB—prostate cancer	2.92e-06	1.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JAK2—prostate cancer	2.91e-06	1.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—prostate cancer	2.89e-06	1.83e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ITPR1—prostate cancer	2.89e-06	1.83e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.88e-06	1.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—INS—prostate cancer	2.86e-06	1.82e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.86e-06	1.81e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MDM2—prostate cancer	2.84e-06	1.8e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.84e-06	1.8e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CREBBP—prostate cancer	2.8e-06	1.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB2—prostate cancer	2.8e-06	1.78e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTT1—prostate cancer	2.79e-06	1.77e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACHE—prostate cancer	2.79e-06	1.77e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CB—prostate cancer	2.77e-06	1.76e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.76e-06	1.75e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TYMS—prostate cancer	2.73e-06	1.73e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTM1—prostate cancer	2.7e-06	1.71e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.69e-06	1.7e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PRKACB—prostate cancer	2.67e-06	1.69e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CD—prostate cancer	2.66e-06	1.69e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LPL—prostate cancer	2.65e-06	1.68e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.64e-06	1.68e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1B—prostate cancer	2.6e-06	1.65e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.56e-06	1.62e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ERCC2—prostate cancer	2.54e-06	1.61e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTEN—prostate cancer	2.52e-06	1.6e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOA2—prostate cancer	2.52e-06	1.6e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NOS3—prostate cancer	2.51e-06	1.59e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CTNNB1—prostate cancer	2.45e-06	1.56e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—EP300—prostate cancer	2.41e-06	1.53e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.4e-06	1.52e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1A—prostate cancer	2.4e-06	1.52e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTEN—prostate cancer	2.39e-06	1.52e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—prostate cancer	2.38e-06	1.51e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.35e-06	1.49e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARA—prostate cancer	2.34e-06	1.48e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NQO1—prostate cancer	2.32e-06	1.47e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CB—prostate cancer	2.32e-06	1.47e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TH—prostate cancer	2.29e-06	1.45e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EP300—prostate cancer	2.28e-06	1.45e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.23e-06	1.41e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SRC—prostate cancer	2.22e-06	1.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAV1—prostate cancer	2.2e-06	1.39e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GGT1—prostate cancer	2.16e-06	1.37e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—prostate cancer	2.14e-06	1.36e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOA1—prostate cancer	2.12e-06	1.35e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.1e-06	1.33e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.09e-06	1.33e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—RXRA—prostate cancer	2.02e-06	1.28e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CG—prostate cancer	2e-06	1.27e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTEN—prostate cancer	2e-06	1.27e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—prostate cancer	1.99e-06	1.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—prostate cancer	1.98e-06	1.26e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—COMT—prostate cancer	1.95e-06	1.23e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—prostate cancer	1.94e-06	1.23e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.94e-06	1.23e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—EP300—prostate cancer	1.91e-06	1.21e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.91e-06	1.21e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—INS—prostate cancer	1.9e-06	1.2e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CREBBP—prostate cancer	1.86e-06	1.18e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KRAS—prostate cancer	1.84e-06	1.16e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TYMS—prostate cancer	1.8e-06	1.14e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—prostate cancer	1.78e-06	1.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.78e-06	1.13e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.76e-06	1.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LPL—prostate cancer	1.75e-06	1.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—prostate cancer	1.69e-06	1.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.69e-06	1.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.67e-06	1.06e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NOS3—prostate cancer	1.66e-06	1.05e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.57e-06	9.97e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARA—prostate cancer	1.54e-06	9.78e-06	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.54e-06	9.73e-06	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—prostate cancer	1.52e-06	9.65e-06	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—prostate cancer	1.49e-06	9.48e-06	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—prostate cancer	1.45e-06	9.22e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAV1—prostate cancer	1.45e-06	9.2e-06	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—prostate cancer	1.41e-06	8.96e-06	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—prostate cancer	1.38e-06	8.74e-06	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTEN—prostate cancer	1.33e-06	8.41e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.32e-06	8.38e-06	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—EP300—prostate cancer	1.27e-06	8.02e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—INS—prostate cancer	1.25e-06	7.93e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.23e-06	7.77e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.16e-06	7.37e-06	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—prostate cancer	1.15e-06	7.32e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NOS3—prostate cancer	1.1e-06	6.96e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.01e-06	6.42e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—prostate cancer	1e-06	6.36e-06	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—prostate cancer	9.36e-07	5.93e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTEN—prostate cancer	8.75e-07	5.55e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—EP300—prostate cancer	8.34e-07	5.29e-06	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—prostate cancer	7.64e-07	4.85e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.17e-07	3.91e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—prostate cancer	5.04e-07	3.2e-06	CbGpPWpGaD
